Cargando…
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
BACKGROUND: This study evaluated the association between early tumor response at 8 weeks, previously reported as a positive outcome prognosticator, and health-related quality of life (HRQOL) in advanced gastric cancer (AGC) patients enrolled in the ABSOLUTE trial. METHODS: HRQOL was assessed using t...
Autores principales: | Fujitani, Kazumasa, Shitara, Kohei, Takashima, Atsuo, Koeda, Keisuke, Hara, Hiroki, Nakayama, Norisuke, Hironaka, Shuichi, Nishikawa, Kazuhiro, Kimura, Yutaka, Amagai, Kenji, Hosaka, Hisashi, Komatsu, Yoshito, Shimada, Ken, Kawabata, Ryohei, Ohdan, Hideki, Kodera, Yasuhiro, Nakamura, Masato, Nakajima, Takako Eguchi, Miyata, Yoshinori, Moriwaki, Toshikazu, Kusumoto, Tetsuya, Nishikawa, Kazuo, Ogata, Kazuhiro, Shimura, Masashi, Morita, Satoshi, Koizumi, Wasaburo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902565/ https://www.ncbi.nlm.nih.gov/pubmed/33136231 http://dx.doi.org/10.1007/s10120-020-01131-y |
Ejemplares similares
-
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial
por: Fujitani, Kazumasa, et al.
Publicado: (2020) -
Peritoneal metastasis as a predictive factor for nab-paclitaxel in patients with pretreated advanced gastric cancer: an exploratory analysis of the phase III ABSOLUTE trial
por: Takashima, Atsuo, et al.
Publicado: (2018) -
Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer
por: Yamada, Yasuhide, et al.
Publicado: (2019) -
Single nucleotide polymorphism genotyping of Erysipelothrix
rhusiopathiae isolates from pigs affected with chronic erysipelas in
Japan
por: SHIRAIWA, Kazumasa, et al.
Publicado: (2017) -
Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis
por: Shitara, Kohei, et al.
Publicado: (2011)